Home > PE Ratio > CORAL LABORATORIES

CORAL LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of CORAL LABORATORIES is 14.70.

Share Price ₹372.0Apr 18,2024
Market Cap ₹133.9 Cr
Earnings-TTM₹9.1 CrTTM-Standalone Results
Price/Earnings14.70xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for CORAL LABORATORIES
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of CORAL LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of CORAL LABORATORIES is calculated as :

Current Market Cap [ ₹133.9 Cr] as on Apr 18,2024

(/) Earnings [ ₹9.1 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 14.70x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for CORAL LABORATORIES , the investors are currently willing to pay 14.70 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CORAL LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of CORAL LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of CORAL LABORATORIES


PE Ratio Performance Analysis for CORAL LABORATORIES

- CORAL LABORATORIES 's latest p/e ratio is 14.70x.

- CORAL LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 9.45x.

- CORAL LABORATORIES 's operated at median p/e ratio of 10.08x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CORAL LABORATORIES 's p/e ratio peaked in Mar2023 at 12.69x.

- CORAL LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 4.91x.


How does CORAL LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
CORAL LABORATORIES 9.1114.70133.9
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.45364,015.0
CIPLA LTD3,744.0329.06108,809.0
DR REDDYS LABORATORIES LTD5,209.4019.0899,408.7
ZYDUS LIFESCIENCES LTD2,954.2031.8994,213.7
DIVIS LABORATORIES LTD1,382.9771.3698,684.0
MANKIND PHARMA LTD1,743.3055.0996,037.1
TORRENT PHARMACEUTICALS LTD1,494.0057.7186,219.0
LUPIN LTD1,809.7440.1372,621.1
AUROBINDO PHARMA LTD2,777.8923.5265,326.3
ABBOTT INDIA LTD1,145.5848.3355,366.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CORAL LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 14.70x
Max industry PE 71.36x
Median industry PE 40.13x
Average industry PE 39.21x



You may also like the below Video Courses